LuciRibo 200 mg is an anticancer medicine used in the treatment of hormone receptor positive advanced breast cancer. It is often used in combination with hormone therapy to improve treatment outcomes. This medicine works by slowing the growth of cancer cells and helping manage disease progression. It is widely prescribed in oncology settings across the United Kingdom, United States, Australia, Singapore and Philippines. LuciRibo supports patients in achieving better control of cancer symptoms and enhances overall treatment effectiveness under medical supervision.
Active Ingredient
Ribociclib is a cyclin dependent kinase inhibitor that targets CDK4 and CDK6 proteins. These proteins are involved in cell cycle progression and cancer cell proliferation. By inhibiting their activity ribociclib slows tumor growth and improves treatment response.
Uses of LuciRibo 200 mg
• Treatment of advanced breast cancer
• Management of hormone receptor positive cancer
• Relief from cancer progression symptoms
• Support for combination cancer therapy
How LuciRibo 200 mg Works
Ribociclib blocks CDK4 and CDK6 enzymes which regulate cell division. By inhibiting these enzymes it prevents cancer cells from progressing through the cell cycle thereby slowing their growth and spread.
How to Use LuciRibo 200 mg
1. Take as prescribed by your oncologist
2. Swallow tablets whole with water
3. Follow treatment cycles strictly
Possible Side Effects
• Fatigue
• Nausea
• Hair thinning
• Low white blood cell count
Precautions
• Regular blood monitoring is required
• Avoid during pregnancy
• Inform doctor about heart conditions
Safety Information
Take LuciRibo only under specialist supervision. Regular tests and follow up visits are essential to monitor response and safety.
Storage
• Store below 30°C
• Keep in original packaging
• Keep away from children
